276 related articles for article (PubMed ID: 29856080)
1. New-onset epilepsy in the elderly.
Vu LC; Piccenna L; Kwan P; O'Brien TJ
Br J Clin Pharmacol; 2018 Oct; 84(10):2208-2217. PubMed ID: 29856080
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
3. Treatment of epilepsy for people with Alzheimer's disease.
Liu J; Wang LN
Cochrane Database Syst Rev; 2021 May; 5(5):CD011922. PubMed ID: 33973646
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Weston J; Marson AG
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment of epilepsy: special issues in treating the elderly.
Bergey GK
Neurology; 2004 Nov; 63(10 Suppl 4):S40-8. PubMed ID: 15557550
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
10. Treatments for seizures in catamenial (menstrual-related) epilepsy.
Maguire MJ; Nevitt SJ
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013225. PubMed ID: 34528245
[TBL] [Abstract][Full Text] [Related]
11. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T
Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973
[TBL] [Abstract][Full Text] [Related]
12. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine add-on for drug-resistant partial epilepsy.
Ramaratnam S; Panebianco M; Marson AG
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
18. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Hemming K; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
[TBL] [Abstract][Full Text] [Related]
19. Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy.
Al-Aqeel S; Gershuni O; Al-Sabhan J; Hiligsmann M
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD008312. PubMed ID: 33089492
[TBL] [Abstract][Full Text] [Related]
20. Rufinamide add-on therapy for drug-resistant epilepsy.
Panebianco M; Prabhakar H; Marson AG
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
